R P Sarkany

Summary

Affiliation: National Institute for Medical Research
Country: UK

Publications

  1. ncbi The management of porphyria cutanea tarda
    R P Sarkany
    Photobiology Department, St John s Institute of Dermatology, St Thomas s Hospital, London, UK
    Clin Exp Dermatol 26:225-32. 2001
  2. ncbi Erythropoietic protoporphyria (EPP) at 40. Where are we now?
    R P E Sarkany
    Photobiology Department, St John s Institute of Dermatology, St Thomas s Hospital, Lambeth Palace Road, London SE1 7EH, UK
    Photodermatol Photoimmunol Photomed 18:147-52. 2002
  3. ncbi A memorable patient - A nasty surprise
    R P E Sarkany
    St. George's Hospital, London
    Clin Exp Dermatol 27:537-8. 2002
  4. ncbi Ferrochelatase gene polymorphism analysis for accurate genetic counselling in erythropoietic protoporphyria
    S D Morris
    St John s Institute of Dermatology, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, U K
    Br J Dermatol 147:572-4. 2002
  5. ncbi Acquired erythropoietic protoporphyria as a result of myelodysplasia causing loss of chromosome 18
    R P E Sarkany
    Department of Dermatology, St George s Hospital and Medical School, Blackshaw Road, London SW17 0QT, U K
    Br J Dermatol 155:464-6. 2006

Collaborators

  • S D Morris
  • G H Elder
  • J L M Hawk
  • N G Mason

Detail Information

Publications5

  1. ncbi The management of porphyria cutanea tarda
    R P Sarkany
    Photobiology Department, St John s Institute of Dermatology, St Thomas s Hospital, London, UK
    Clin Exp Dermatol 26:225-32. 2001
    ..Subsequently, long-term follow-up is needed in all patients to monitor for relapse...
  2. ncbi Erythropoietic protoporphyria (EPP) at 40. Where are we now?
    R P E Sarkany
    Photobiology Department, St John s Institute of Dermatology, St Thomas s Hospital, Lambeth Palace Road, London SE1 7EH, UK
    Photodermatol Photoimmunol Photomed 18:147-52. 2002
    ..This review summarises laboratory and clinical progress in EPP in the past 40 years, and assesses the potential impact of molecular biology on clinical practice...
  3. ncbi A memorable patient - A nasty surprise
    R P E Sarkany
    St. George's Hospital, London
    Clin Exp Dermatol 27:537-8. 2002
  4. ncbi Ferrochelatase gene polymorphism analysis for accurate genetic counselling in erythropoietic protoporphyria
    S D Morris
    St John s Institute of Dermatology, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, U K
    Br J Dermatol 147:572-4. 2002
    ..We describe a patient and his spouse in whom we have used such genetic analysis to provide an accurate estimate of the chance that their future offspring may suffer from EPP...
  5. ncbi Acquired erythropoietic protoporphyria as a result of myelodysplasia causing loss of chromosome 18
    R P E Sarkany
    Department of Dermatology, St George s Hospital and Medical School, Blackshaw Road, London SW17 0QT, U K
    Br J Dermatol 155:464-6. 2006
    ..The nature of the remaining ferrochelatase allele was examined by polymorphism analysis and we discuss the insights that this patient's genotype may reveal about the pathogenesis of porphyria in myelodysplasia...